Bortezomib and Lenalidomide (VR) Consolidation Post-ASCT without Dexamethasone and Bisphosphonates: Final Analysis of a Prospective Study

Evangelos Terpos; Efstathios Kastritis; Dimitrios Christoulas; Evangelos Eleutherakis‐Papaiakovou; Maria Gavriatopoulou; Despina Fotiou; Ioannis Panagiotidis; Dimitrios C. Ziogas; Magdalini Migkou; Μαρία Ρούσσου; Meletios A Dimopoulos

doi:10.1016/j.clml.2017.03.259

Related publications

Article2013

VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT

Evangelos Terpos, D. Christoulas, Efstathios Kastritis, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Μαρία Γκοτζαμανίδου, Nikolaos Kanellias, Efstathios Manios, C. Papadimitriou, Meletios A Dimopoulos

Article2024

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Thierry Façon, Meletios A Dimopoulos, Xavier P Leleu, Meral Beksac, Ludek Pour, Roman Hájek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko‐Jarosińska, Ivan Spicka, Vladimir Vorobyev, Britta Besemer, Tadao Ishida, Wojciech Janowski, Sevgi Kalayoğlu Beşışık, Gurdeep Parmar, Paweł Robak, Elena Zamagni, Hartmut Goldschmidt, Thomas Martin, Salomon Manier, Mohamad Mohty, Corina Oprea, Marie-France Brégeault, Sandrine Macé, Christelle Berthou, David Bregman, Zandra Klippel, Robert Z Orlowski

Article2023

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen,

Article2022

P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study

Alessandra Larocca, Katja Weisel, Mónica Galli, Albert Oriol, Thierry Façon, Sujith Dhanasiri, Kevin Hong, Christian Gentili, Yutian Mu, Shien Guo, Fredrik Schjesvold, Meletios A Dimopoulos, Paul G. Richardson

Article2009

The Addition of Bortezomib to the Combination of Lenalidomide and Dexamethasone Increases Bone Formation in Relapsed/Refractory Myeloma: a Prospective Study in 91 Patients.

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Μαρία Ρούσσου, Maria Gavriatopoulou, Magdalini Migkou, Μαρία Γκοτζαμανίδου, Marina Iakovaki, Αθανάσιος Παπαθεοδώρου, Meletios A Dimopoulos